Literature DB >> 12615431

Super-activated interferon-regulatory factors can enhance plasmid immunization.

Jonathan L Bramson1, Kelley Dayball, Jennifer R Hall, James B Millar, Mark Miller, Yong Hong Wan, Rongtuan Lin, John Hiscott.   

Abstract

We have been investigating the adjuvant properties of two super-activated interferon-regulatory factors (IRFs), IRF-3(5D) and IRF7/3A, identified in our previous studies of structure-function relationships, for enhancing plasmid vaccines. Intramuscular injection of plasmid cocktails encoding IRF-3(5D) and IRF7/3A molecules elicited cytotoxic T cell responses in over 80% of mice following a single immunization compared to a 20% response-rate using a control cocktail. Most interestingly, greater than 60% of mice immunized with the super-activated IRFs developed antigen-specific antibodies compared to 0% of the mice in the control group. Finally, vaccines which incorporated the super-activated IRFs provided greater protection against challenge with a recombinant vaccinia virus. These results support further investigation of the potential of these agents as adjuvants for genetic immunization.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12615431     DOI: 10.1016/s0264-410x(02)00694-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  14 in total

1.  Coexpressed RIG-I agonist enhances humoral immune response to influenza virus DNA vaccine.

Authors:  Jeremy M Luke; Gregory G Simon; Jonas Söderholm; John S Errett; J Thomas August; Michael Gale; Clague P Hodgson; James A Williams
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

Review 2.  Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses.

Authors:  Karl-Klaus Conzelmann
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

3.  Biomaterials at the interface of nano- and micro-scale vector-cellular interactions in genetic vaccine design.

Authors:  Charles H Jones; Anders P Hakansson; Blaine A Pfeifer
Journal:  J Mater Chem B       Date:  2014-09-12       Impact factor: 6.331

Review 4.  DNA vaccines for prostate cancer.

Authors:  Christopher D Zahm; Viswa Teja Colluru; Douglas G McNeel
Journal:  Pharmacol Ther       Date:  2017-02-07       Impact factor: 12.310

5.  Gene therapeutic approach for inhibiting hepatitis C virus replication using a recombinant protein that controls interferon expression.

Authors:  Chul Hyun Joo; Uk Lee; Young Ran Nam; Jae U Jung; Heuiran Lee; Young Keol Cho; Yoo Kyum Kim
Journal:  Antimicrob Agents Chemother       Date:  2010-09-20       Impact factor: 5.191

6.  Expression of porcine fusion protein IRF7/3(5D) efficiently controls foot-and-mouth disease virus replication.

Authors:  Lisbeth Ramírez-Carvajal; Fayna Díaz-San Segundo; Danielle Hickman; Charles R Long; James Zhu; Luis L Rodríguez; Teresa de los Santos
Journal:  J Virol       Date:  2014-07-16       Impact factor: 5.103

7.  Role of innate signalling pathways in the immunogenicity of alphaviral replicon-based vaccines.

Authors:  Tanja I Näslund; Linda Kostic; Eva Kl Nordström; Margaret Chen; Peter Liljeström
Journal:  Virol J       Date:  2011-01-24       Impact factor: 4.099

8.  Characterizing complex polysera produced by antigen-specific immunization through the use of affinity-selected mimotopes.

Authors:  Galina Denisova; Dimitri Denisov; Carole Evelegh; Michaela Weissgram; Jochen Beck; Stephen Ronan Foley; Jonathan Lorne Bramson
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

Review 9.  Innate Immune Signaling by, and Genetic Adjuvants for DNA Vaccination.

Authors:  Kouji Kobiyama; Nao Jounai; Taiki Aoshi; Miyuki Tozuka; Fumihiko Takeshita; Cevayir Coban; Ken J Ishii
Journal:  Vaccines (Basel)       Date:  2013-07-18

10.  Immunogenicity and efficacy of a plasmid DNA rabies vaccine incorporating Myd88 as a genetic adjuvant.

Authors:  Padinjaremattathil Thankappan Ullas; Anita Desai; Shampur Narayan Madhusudana
Journal:  Clin Exp Vaccine Res       Date:  2014-06-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.